Triggiani, L., Mazzola, R., Magrini, S. M., Alongi, F., & Buglione, M. (2018). Reply to ‘Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: New evidence from a multicentric study’’. Br J Cancer.
Citação norma ChicagoTriggiani, Luca, Rosario Mazzola, Stefano Maria Magrini, Filippo Alongi, and Michela Buglione. "Reply to ‘Comment On ‘Efficacy of Stereotactic Body Radiotherapy in Oligorecurrent and in Oligoprogressive Prostate Cancer: New Evidence From a Multicentric Study’’." Br J Cancer 2018.
MLA CitationTriggiani, Luca, et al. "Reply to ‘Comment On ‘Efficacy of Stereotactic Body Radiotherapy in Oligorecurrent and in Oligoprogressive Prostate Cancer: New Evidence From a Multicentric Study’’." Br J Cancer 2018.